Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_998_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
26 Мб
Скачать
14 Biomimetics: ANew Abstraction forBone Implant Design
https://t.me/medicina_free
155
14.7 Conclusions
In order to medically complete bone regenera­tion, the current therapies must evolve in accor­dance with current research. Biomimetics drives creativity and innovation to emulate the healing mechanisms already in place. Due to the biologi­cal nature of much of the research mentioned in this chapter, product development still faces con­siderable regulatory hurdles. However, the base­line knowledge derived from experiments and research listed herein is a great platform upon which therapies can be built. The biomimetic boundaries to be pushed in bone regeneration are collagen or collagen analogs, soluble minerals, and active cell populations.
References
1. Kumar P, Vinitha B, Fathima G.Bone grafts in den-
tistry. J Pharm Bioallied Sci. 2013;5(Suppl 1):S125–7.
2. Esposito M, Hirsch JM, Lekholm U, Thomsen
P.Biological factors contributing to failures of osseo­integrated oral implants. (I). Success criteria and epi­demiology. Eur J Oral Sci. 1998;106(1):527–51.
3. Cavallaro A, Lo Menzo E, Di Vita M, Zanghi A,
Cavallaro V, Veroux PF, Cappellani A. Use of bio­logical meshes for abdominal wall reconstruction in highly contaminated elds. World J Gastroenterol. 2010;16(15):1928–33.
4. Merheb J, Temmerman A, Rasmusson L, Kubler A,
Thor A, Quirynen M.Inuence of skeletal and local bone density on dental implant stability in patients with osteoporosis. Clin Implant Dent Relat Res. 2016;18(2):253–60.
5. Funao H, Nagai S, Sasaki A, Hoshikawa T, Tsuji T,
Okada Y, Koyasu S, Toyama Y, Nakamura M, Aizawa M, Matsumoto M, Ishii K. A novel hydroxyapatite lm coated with ionic silver via inositol hexaphos­phate chelation prevents implant-associated infection. Sci Rep. 2016;6:23238.
6. von Eiff C, Peters G, Heilmann C. Pathogenesis of
infections due to coagulase-negative staphylococci. Lancet Infect Dis. 2002;2(11):677–85.
7. Winter W, Karl M.Basic considerations for determin-
ing the amount of press t in acetabular cup endo­prostheses as a function of the elastic bone behavior. Biomed Tech. 2014;59(5):413–20.
8. Pesce V, Speciale D, Sammarco G, Patella S,
Spinarelli A, Patella V. Surgical approach to bone healing in osteoporosis. Clin Cases Miner Bone Metab. 2009;6(2):131–5.
9. Laschke MW, Harder Y, Amon M, Martin I,
Farhadi J, Ring A, Torio-Padron N, Schramm
R, Rücker M, Junker D, Häufel JM, Carvalho C, Heberer M, Germann G, Vollmar B, Menger MD.Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng. 2006;12(8):2093–104.
10. Wu Y, Chen L, Scott PG, Tredget EE.Mesenchymal stem cells enhance wound healing through dif­ferentiation and angiogenesis. Stem Cells. 2007;25(10):2648–59.
11. Wu C, Zhou Y, Fan W, Han P, Chang J, Yuen J, Zhang M, Xiao Y. Hypoxia-mimicking mesoporous bio­active glass scaffolds with controllable cobalt ion release for bone tissue engineering. Biomaterials. 2012;33(7):2076–85.
12. Rho JY, Ashman RB, Turner CH. Young’s modu­lus of trabecular and cortical bone material: ultra­sonic and microtensile measurements. J Biomech. 1993;26(2):111–9.
13. Niinomi M, Nakai M. Titanium-based biomateri­als for preventing stress shielding between implant devices and bone. Int J Biomater. 2011;2011:836587.
14. Gao SS, Zhang YR, Zhu ZL, Yu HY. Micromotions and combined damages at the dental implant/bone interface. Int J Oral Sci. 2012;4(4):182–8.
15. Müller M, Hennig FF, Hothorn T, Stangl R. Bone­implant interface shear modulus and ultimate stress in a transcortical rabbit model of open-pore Ti6Al4V implants. J Biomech. 2013;39(11):2123–32.
16. Schmalzried TP, Jasty M, Harris WH.Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg. 1992;74(6):849–63.
17. Urban RM, Jacobs JJ, Tomlinson MJ, Gavrilovic J, Black J, Peoc’h M. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg. 2000;82(4):457–76.
18. Albrektsson T, Branemark PI, Hansson HA, Lindstrom J. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone­to- implant anchorage in man. Acta Orthop Scand. 1981;52(2):155–70.
19. Duyck J, Vandamme K, Geris L, Van Oosterwyck H, De Cooman M, Vandersloten J, et al. The inuence of micro-motion on the tissue differentiation around immediately loaded cylindrical turned titanium implants. Arch Oral Biol. 2006;51(1):1–9.
20. Casella D, Calabrese C, Bianchi S, Meattini I, Bernini M. Subcutaneous tissue expander placement with synthetic titanium-coated mesh in breast reconstruc­tion: long-term results. Plast Reconstr Surg Glob Open. 2015;3(12):e577.
21. Dursun CK, Dursun E, Eratalay K, Orhan K, Tatar I, Baris E, Tözüm TF.Effect of porous titanium granules on bone regeneration and primary stability in maxil­lary sinus: a human clinical, histomorphometric, and microcomputed tomography analyses. J Craniofac Surg. 2016;27(2):391–7.
22. Gruen TA, McNeice GM, Amstutz HC. "Modes of failure" of cemented stem-type femoral components:
156
https://t.me/medicina_free
E. A. Brett et al.
a radiographic analysis of loosening. Clin Orthop Relat Res. 1979;141:17–27.
23. Boskey AL.Bone composition: relationship to bone fragility and antiosteoporotic drug effects. Bonekey Rep. 2013;2:447.
24. Westbroek P, Marin F.A marriage of bone and nacre. Nature. 1998;392(6679):861–2.
25. Kattimani VS, Chakravarthi SP, Neelima Devi KN, Sridhar MS, Prasad LK. Comparative evaluation of bovine derived hydroxyapatite and synthetic hydroxy­apatite graft in bone regeneration of human maxillary cystic defects: a clinico-radiological study. Indian J Dental Res. 2014;25(5):594–601.
26. Cao H, Kuboyama N.A biodegradable porous com­posite scaffold of PGA/beta-TCP for bone tissue engi­neering. Bone. 2010;46(2):386–95.
27. Calin C, Patrascu I. Growth factors and beta­tricalcium phosphate in the treatment of periodontal intraosseous defects: a systematic review and meta­analysis of randomised controlled trials. Arch Oral Biol. 2016;66:44–54.
28. Walsh WR, Vizesi F, Michael D, Auld J, Langdown A, Oliver R, Yu Y, Irie H, Bruce W.Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials. 2008;29(3):266–71.
29. Tanner KE. Bioactive ceramic-reinforced com­posites for bone augmentation. J R Soc Interface. 2010;7(Suppl 5):S541–57.
30. Damien E, Revell PA.Coralline hydroxyapatite bone graft substitute: a review of experimental studies and biomedical applications. J Appl Biomater Biomech. 2004;2(2):65–73.
31. Vago R, Plotquin D, Bunin A, Sinelnikov I, Atar D, Itzhak D.Hard tissue remodeling using biofabricated coralline biomaterials. J Biochem Biophys Methods. 2002;50(2–3):253–9.
32. Serban MA, Prestwich GD. Modular extracel­lular matrices: solutions for the puzzle. Methods. 2008;45(1):93–8.
33. Davidson JM, Nanney LB, Broadley KN, Whitsett JS, Aquino AM, Beccaro M, Rastrelli A.Hyaluronate derivatives and their application to wound heal­ing: preliminary observations. Clin Mater. 1991;8(1–2):171–7.
34. Aslan M, Simsek G, Dayi E. The effect of hyal­uronic acid-supplemented bone graft in bone heal­ing: experimental study in rabbits. J Biomater Appl. 2006;20(3):209–20.
35. Subramaniam S, Fang YH, Sivasubramanian S, Lin FH, Lin CP. Hydroxyapatite-calcium sulfate­hyaluronic acid composite encapsulated with collage­nase as bone substitute for alveolar bone regeneration. Biomaterials. 2016;74:99–108.
36. Gohil SV, Adams DJ, Maye P, Rowe DW, Nair LS.Evaluation of rhBMP-2 and bone marrow derived stromal cell mediated bone regeneration using trans­genic uorescent protein reporter mice. J Biomed Mater Res A. 2014;102(12):4568–80.
37. Finley JM, Acland RD, Wood MB. Revascularized periosteal grafts--a new method to produce functional
new bone without bone grafting. Plast Reconstr Surg. 1978;61(1):1–6.
38. Ueno T, Kagawa T, Mizukawa N, Nakamura H, Sugahara T, Yamamoto T. Cellular origin of endo­chondral ossication from grafted periosteum. Anat Rec. 2001;264(4):348–57.
39. Zhang X, Awad HA, O’Keefe RJ, Guldberg RE, Schwarz EM.A perspective: engineering periosteum for structural bone graft healing. Clin Orthop Relat Res. 2008;466(8):1777–87.
40. Mahajan A. Periosteum: a highly underrated tool in dentistry. Int J Dent. 2012;2012:717816.
41. Gomez-Barrena E, Rosset P, Lozano D, Stanovici J, Ermthaller C, Gerbhard F. Bone fracture healing: cell therapy in delayed unions and nonunions. Bone. 2015;70:93–101.
42. Giannoudis PV, Einhorn TA, Marsh D.Fracture heal­ing: the diamond concept. Injury. 2007;38(Suppl
4):S3–6.
43. Liao HT, Chen CT.Osteogenic potential: comparison between bone marrow and adipose-derived mesenchy­mal stem cells. World J Stem Cells. 2014;6(3):288–95.
44. Wan DC, Shi YY, Nacamuli RP, Quarto N, Lyons KM, Longaker MT. Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein recep­tor type IB signaling. Proc Natl Acad Sci U S A. 2006;103(33):12335–40.
45. Quarto N, Wan DC, Longaker MT.Molecular mech­anisms of FGF-2 inhibitory activity in the osteo­genic context of mouse adipose-derived stem cells (mASCs). Bone. 2008;42(6):1040–52.
46. McArdle A, Chung MT, Paik KJ, Duldulao C, Chan C, Rennert R, Walmsley GG, Senarath-Yapa K, Hu M, Seo E, Lee M, Wan DC, Longaker MT.Positive selec­tion for bone morphogenetic protein receptor type-IB promotes differentiation and specication of human adipose-derived stromal cells toward an osteogenic lineage. Tissue Eng A. 2014;20(21–22):3031–40.
47. Chung MT, Liu C, Hyun JS, Lo DD, Montoro DT, Hasegawa M, Li S, Sorkin M, Rennert R, Keeney M, Yang F, Quarto N, Longaker MT, Wan DC. CD90 (Thy-1)-positive selection enhances osteogenic capacity of human adipose-derived stromal cells. Tissue Eng A. 2013;19(7–8):989–97.
48. Yamamoto M, Nakata H, Hao J, Chou J, Kasugai S, Kuroda S. Osteogenic potential of mouse adipose­derived stem cells sorted for cd90 and cd105 invitro. Stem Cells Int. 2014;2014:17.
49. Wiesmann A, Bühring HJ, Mentrup C, Wiesmann HP.Decreased CD90 expression in human mesenchy­mal stem cells by applying mechanical stimulation. Head Face Med. 2006;2:8.
50. Levi B, Wan DC, Glotzbach JP, Hyun J, Januszyk M, Montoro D, Sorkin M, James AW, Nelson ER, Li S, Quarto N, Lee M, Gurtner GC, Longaker MT.CD105 protein depletion enhances human adipose-derived stromal cell osteogenesis through reduction of trans­forming growth factor beta1 (TGF-beta1) signaling. J Biol Chem. 2011;286(45):39497–509.
14 Biomimetics: ANew Abstraction forBone Implant Design
https://t.me/medicina_free
157
51. Zhang L, Magli A, Catanese J, Xu Z, Kyba M, Perlingeiro RC.Modulation of TGF-beta signaling by endoglin in murine hemangioblast development and primitive hematopoiesis. Blood. 2011;118(1):88–97.
52. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Inuence of the number and con­centration of progenitor cells. J Bone Joint Surg. 2005;87(7):1430–7.
53. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK. Transplantability and therapeutic effects of bone marrow-derived mesen-
chymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5(3):309–13.
54. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, Kon E, Marcacci M.Repair of large bone defects with the use of autol­ogous bone marrow stromal cells. N Engl J Med. 2001;344(5):385–6.
55. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology. 1997;138(10):4456–62.
The Role ofMicrobiota inSkin
https://t.me/medicina_free
Regeneration
AngelaFaga, MarcoMarioTresoldi, andGiovanniNicoletti
15
15.1 Introduction
Regeneration can be dened as the regrowth of a damaged or missing organ part from the remain­ing tissue. It is a common feature in different ani­mal species, as amphibians; on the contrary, in humans the wound healing process does not lead to regeneration but to a scar. Actually humans are not lizards; therefore, they pay their position at the endpoint of phylogeny with an almost total loss of the regenerative attitude, except for liver and, sometimes, for ngertips [1].
Everyday plastic surgeons face disguring or
aesthetically impairing scars, huge loss of sub-
A. Faga (*) Advanced Technologies for Regenerative Medicine and Inductive Surgery Research Center (T.A.Me.Ri.C.I.), University of Pavia, Pavia, Italy e-mail: angela.faga@unipv.it
M. M. Tresoldi Plastic Surgery Unit, Department of Clinical­Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy
I.C.S. Maugeri Research and Care Institute, Pavia, Italy e-mail: marcomario.tresoldi@unipv.it
G. Nicoletti Advanced Technologies for Regenerative Medicine and Inductive Surgery Research Center (T.A.Me.Ri.C.I.), University of Pavia, Pavia, Italy
Plastic Surgery Unit, Department of Clinical­Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy e-mail: giovanni.nicoletti@unipv.it
stance or difcult to heal wounds. Despite the current high sophisticated technical skills, the problem of regeneration is impairing severely the treatment of all of these clinical problems. Therefore, current plastic surgery is increasingly turning to regenerative medicine, an emerging interdisciplinary eld of research and clinical applications focused on the repair, replacement or regeneration of cells, tissues or organs [2].
The wound healing process consists of highly integrated and overlapping phases, whose steps are clot formation, inammation, broblasts recruitment, epithelization and scar remodelling.
Many types of immune and non-immune cells, including macrophages, neutrophils, plate­lets, broblasts, vascular endothelial cells and keratinocytes, contribute to wound healing. The inammatory response begins immediately upon injury and leads to the secretion of a variety of growth factors and cytokines, which regulate the cellular and tissue movements that are required for repair [3, 4]. It is proven that the proliferative phase of wound healing is inversely proportional to the quantity of inammatory post-traumatic reaction [5].
Multiple local and systemic factors can inter­fere with one or more of these phases, thus caus­ing improper or impaired tissue repair; the main local barriers are necrosis, bacteria and exudates.
Regarding the negative role of bacteria, sur­geons have slowly learned from Semmelweis’ time [6] to fear and ght microbes by scrubbing their hands before surgery, treating the operating
© Springer Nature Switzerland AG 2019 D. Duscher, M. A. Shiffman (eds.), Regenerative Medicine and Plastic Surgery,
https://doi.org/10.1007/978-3-030-19958-6_15
159
160
https://t.me/medicina_free
A. Faga et al.
eld with antiseptics and administering antibiotics to the patients. Actually, the infection of a wound turns to dehisce and to a clinical disaster.
In the past, the role of microorganisms was investigated only during pathologic events; how­ever, the availability of upgraded technologies is currently allowing a more sophisticated and thor­ough analysis of their association with the host.
Microorganisms are present in every type of environmental niche and interplay with all its components.
The term microbiota is used currently to dene the microbial community, composed of bacteria, viruses, fungi and Archaea, hosted by the human body [7]. Actually the microbiota might be con­sidered as a ‘superorganism’ [8], ruled by spe­cic inter-microbial communications and cell signalling associations with the human organism. Host-microbe interactions are essential for vari­ous aspects of normal mammalian physiology, ranging from metabolic activity to immune homeostasis [811].
Every area of the human body hosts a unique microbial community.
Microbial cells living in the human body out­number the totality of cells of our organism by a factor of ten, and the genes of those microbial cells outnumber the human genes by a factor of hundred [12]; the term microbiome is currently used to indicate the whole genome of the micro­bial community.
From 2008, starting with the U.S.A. Human Microbiome Project (HMP), different studies were performed to establish any possible associa­tions between the human microbiota and health and disease conditions [13, 14].
The difculty of recreating the same condi­tions invitro as invivo is a major humper for the microbiota characterization [15]. Thanks to cur­rent metagenomics techniques, it is possible to screen the whole genes of an environmental sam­ple and to create a genetic library of the proteins expressed by the community [16]. Moving from conventional cultures to metagenomics, a per­spective change is occurring, focusing on the activity and products of a whole community, rather than of a single community member [17].
15.2 Skin Microbiota
Skin is the rst defensive line of the human body and houses different populations of microorgan­isms. Every squared centimetre of skin (includ­ing hair follicles and sebaceous glands) contains ~1 billion bacteria [18].
The acquisition of the microbiota begins at birth [19], with the transfer of maternal micro­biota, and differs according to vaginal or cae­sarean delivery. The skin microbiota evolves over the years, becoming similar to that of adults by the age of 12–18 months [20]. Basically, the microbiota composition is related to the skin structure and physiology [21] and to the adnexa-regulated microenvironment. Furthermore, microbiota composition changes according to ethnicity, geography and lifestyle [12]. Individuals modify their own microbiota through contact with other individuals, visiting different places, and eating food. The microbi­ota composition is dependent on the anatomical area too. Microbiota α-diversity expresses the difference in community composition, compar­ing a specic area of the body to other areas of the same individual. Microbiota β-diversity expresses the difference in community compo­sition comparing a specic area of the body between different individuals. Notably, antecu­bital fossae have the highest β-diversity, but the lowest α-diversity [22]. The differences among different individual microbiotas are due to the less represented bacteria.
Most skin microorganisms are commensal or temporary passing members. The following four bacterial phyla are present on human skin: Actinobacteria, Proteobacteria, Firmicutes and Bacteroidetes. Staphylococcus, Propionibacterium and Corynebacterium are the dominant genera, and their inter-individual distribution is constant. Furthermore, on normal human skin viruses (human papillomavirus, human polyomavirus, circovirus and bacteriophages) and eukaryotes microbes (fungi and protists) are present [23]. Considering the community composition in dif­ferent individuals, it is possible to state that the microbiota of an individual is as unique as a n­gerprint [24, 25].
15 The Role ofMicrobiota inSkin Regeneration
https://t.me/medicina_free
161
Microorganisms do not inhabit just the epi­dermis. Metagenomic techniques demonstrate bacterial DNA deep in the dermis too, although such a technology may not assess the viability of the associated microorganisms [12, 23]. Phagocytic cells might translocate the super­cial microbiota to a sub-epidermal level and epidermal physical barriers or antimicrobial peptides (AMPs) would serve as key regulators in the maintenance of dermal microbiome homeostasis [26]. The action of microorgan­isms below the basement membrane might be in correlation with the immunological proper­ties of the skin. The skin is an active immune organ where the keratinocytes can no longer be considered as the sole barrier against the exter­nal environment, but as components of a com­plex immune-regulatory network [27]. The resident skin bacteria provide the rst line of defence against potentially dangerous patho­gens, and produce small molecules that inu­ence the growth and behaviour of their microbial neighbours. The major innate mechanism of the antimicrobial defence of the skin consists of AMPs, such as defensins, cathelicidin LL-37 and dermicidin [28]. These peptides are emerg­ing as important tools in the control of skin pathogenic bacteria. It is proven that skin com­mensal bacteria have a promoting effect on T cell response, controlling nuclear factor-κB sig­nalling and the production of cytokines, such as tumour necrosis factor (TNF)-α and interleukin-1β [29, 30] although they can act both in synergy and in opposition to the immune system [31].
Germ-free mice without commensal skin microbes have been demonstrated to produce abnormal cytokine and cutaneous T cell popula­tions, as they were unable to mount an appropri­ate immune response against the intradermal Leishmania major infection; immunity could be rescued by allowing Staphylococcus epidermi- dis colonization on the mouse skin [30].
As skin microbiota is important in the devel­opment of a well-functioning immune system and in the modulation of the inammatory pro­cesses, it may be signicant in the wound healing process.
15.3 The Role ofMicrobiota inWound Healing
Actually, although many animal species regener­ate spontaneously in the wild life, this process does not take place in a germ-free environment.
While the role of microbiota in controlling the health-disease balance is being widely investi­gated as a source of novel therapeutic options, however the local application of bacterial prod­ucts to enhance wound healing has been reported rarely.
Topical bacterial lipopolysaccharide is dem­onstrated to affect the wound healing process by accelerating the resolution of inammation, increasing macrophage inltration, enhancing collagen synthesis and altering the secretion of numerous mediators involved in skin regenera­tion [32]; moreover, inoculation with Pseudomonas aeruginosa is demonstrated to accelerate re-epithelialization and neovascular­ization in wound tissues through the production of TNF-α [33]. All of these effects might be related, although not exclusively, to some bac­terial both anti-inammatory and antibiotic­like actions, due either to microorganisms metabolites, or to a virtuous balance among strains, or both.
It has long been known that the recovery of skin lesions and scar maturation can be boosted by the topical applications of spring waters where a rich presence of non-pathogenic microora is established [3438].
In recent years, researchers have developed programmes to investigate the molecular mecha­nism underlying benecial effects of spring waters. Aquaphilus dolomiae is a non-spore- forming bacterium belonging to the Neisseriaceae family, which is isolated from Avène thermal water (France), historically used in the manage­ment of chronic inammatory skin diseases. The incubation of human keratinocytes with I-modulia, a biological extract from cultures of Aquaphilus dolomiae, showed an upregulation of the innate immune response [39, 40]. Similarly, the lysate of Vitreoscilla liformis has been shown to enhance skin defence mechanisms and to decrease UV-induced sunburn cells in human
162
https://t.me/medicina_free
A. Faga et al.
skin, possibly by the activation of cutaneous reg­ulatory T cells. Vitreoscilla liformis is a lamen- tous Gram-negative aerobic bacterium belonging to the Neisseriaceae family found in LaRoche­Posay thermal water (France), historically applied to manage chronic inammatory skin diseases [41, 42].
Our research group is originally assessing the peculiar regenerative properties of a thermal spring water (Comano, TN, Italy). In an experi­mental animal (rabbits) wound model, the areas treated with this water healed faster than the areas treated with conventional medical dressings and demonstrated a network of collagen and elastic bres comparable with the normal skin [37]. In an in vitro trial on human skin broblasts cul­tures, we observed that the vitality of cells main­tained in DMEM (Dulbecco enriched conventional medium) 20% replaced with the Comano water, at 72hours was 31% higher than the control cultures maintained in conventional DMEM [43]. Moreover, in an ex vivo human skin experimental wound model, used to simulate the physiological conditions in vivo, the adjunct of this spring water to the culture medium induced a faster repair of the wound, a more ordered reor­ganization of the newly formed collagen bres and a higher number of actively DNA synthesiz­ing epithelial cells [44].
In this spring water with conventional culture methods nine non-pathogenic different strains were isolated, whose common features are a very rare virulence, an antibiotic-like activity and the ability to control environmental pollu­tion [38].The whole bacterial ora genoma is being investigated by the research group of CIBIO laboratories (Trento University, Italy) too, integrating culturomics and shotgun metage­nomics. Preliminary results demonstrate that while the isolates are phylogenetically distrib­uted among traditional phyla (Proteobacteria, Actinobacteria and Firmicutes), most of the metagenome- assembled genomes belong to phyla that are typically recalcitrant to cultiva­tion, and many new species have been isolated or detected [45, 46]. The researchers are also testing specic strains to detect any immune
modulating, proteolytic and anti-bacterial activ­ity, likely related to the proven role of this water in the wound healing process.
Thus, the role of microbiota in the skin health maintenance appears to be of paramount impor­tance and, therefore, indicates towards a hypoth­esis of exerting a positive effect in the skin healing processes.
15.4 Conclusion
The mechanisms on which the microbial commu­nity structure and the association between host and symbiont are based must become incorpo­rated into the current denition of human health. Medical intervention must aim to minimize or avoid damage to health-associated homeostasis between humans and their microbiota; therefore, the therapeutic strategies to maintain healthy skin may require the inhibition of the growth of patho­genic bacteria, as well as the promotion of a bal­anced microbiota. Ignoring the association between host and microbiota in therapeutic plan­ning is a shortsighted conduct, as demonstrated by the spread of antibiotic-resistant microorgan­isms [47]. Thus, the role of microbiota is result­ing in novel and fascinating scenarios in regenerative medicine and surgery, promoting unexpected progress in the development of novel clinical proposals, not only for tissue regenera­tion and wound healing but for anti-ageing pur­poses, too.
References
1. Jafari P, Muller C, Grognuz A, Applegate LA, Raffoul
W, di Summa PG, Durand S.First insights into human ngertip regeneration by Echo-Doppler imaging and wound microenvironment assessment. Int J Mol Sci. 2017;18(1054):1–10.
2. Mason C, Dunnill P.A brief denition of regenerative
medicine. Regen Med. 2008;3(1):1–5.
3. Simpson DM, Ross R. The neutrophilic leukocyte
in wound repair a study with antineutrophil serum. J Clin Invest. 1972;51(8):2009–23.
4. Mast BA, Schultz GS. Interactions of cytokines,
growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 1996;4(4):411–20.
15 The Role ofMicrobiota inSkin Regeneration
https://t.me/medicina_free
163
5. Werner S, Grose R. Regulation of wound heal­ing by growth factors and cytokines. Physiol Rev. 2003;83(3):835–70.
6. Best M, Neuhauser D. Ignaz Semmelweis and the birth of infection control. Qual Saf Health Care. 2004;13(3):233–4.
7. Casadevall A, Pirofski LA. What is a host? Incorporating the microbiota into the damage­response framework. Infect Immun. 2015;83(1):2–7.
8. Foxman B, Goldberg D, Murdock C, Xi C, Gilsdorf JR. Conceptualizing human microbiota: from mul­ticelled organ to ecological community. Interdiscip Perspect Infect Dis. 2008;2008:613979.
9. Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol. 2006;3(5):275–84.
10. Martin FP, Dumas ME, Wang Y, Legido-Quigley C, Yap IK, Tang H, Zirah S, Murphy GM, Cloarec O, Lindon JC, Sprenger N, Fay LB, Kochhar S, van Bladeren P, Holmes E, Nicholson JK. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol. 2007;3:112.
11. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune sys­tem. Cell. 2005;122(1):107–18.
12. Grice EA. The skin microbiome: potential for novel diagnostic and therapeutic approaches to cutaneous disease. Semin Cutan Med Surg. 2014;33(2):98–103.
13. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804–10.
14. NIH HMP Working Group, Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, Baker CC, Di Francesco V, Howcroft TK, Karp RW, Lunsford RD, Wellington CR, Belachew T, Wright M, Giblin C, David H, Mills M, Salomon R, Mullins C, Akolkar B, Begg L, Davis C, Grandison L, Humble M, Khalsa J, Little AR, Peavy H, Pontzer C, Portnoy M, Sayre MH, Starke-Reed P, Zakhari S, Read J, Watson B, Guyer M.The NIH human microbiome roject. Genome Res. 2009;19(12):2317–23.
15. Huss J. Methodology and ontology in microbiome research. Biol Theory. 2014;9(4):392–400.
16. National Research Council (US) Committee on Metagenomics. Challenges and functional applica­tions. The new science of metagenomics: revealing the secrets of our microbial planet. Washington, DC: National Academies Press; 2007.
17. Schloss PD.Microbiology: an integrated view of the skin microbiome. Nature. 2014;514(7520):44–5.
18. Grice EA, Kong HH, Renaud G, Young AC, Bouffard GG, Blakesley RW, Wolfsberg TG, Turner ML, Segre JANISC.Comparative sequencing program: a diver-
sity prole of the human skin microbiota. Genome Res. 2008;18(7):1043–50.
19. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R.Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010 Jun;107(26):11971–5.
20. Capone KA, Dowd SE, Stamatas GN, Nikolovski J. Diversity of the human skin microbiome early in life. J Invest Dermatol. 2011;131(10):2026–32.
21. Baviera G, Leoni MC, Capra L, Cipriani F, Longo G, Maiello N, Ricci G, Galli E. Microbiota in healthy skin and in atopic eczema. Biomed Res Int. 2014;2014:436921.
22. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbi­ome. Nature. 2012;86(7402):207–14.
23. Findley K, Grice EA.The skin microbiome: a focus on pathogens and their association with skin disease. PLoS Pathog. 2014;10(10):e1004436.
24. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R, Gordon JI, Knight R.Bacterial community variation in human body habitats across space and time. Science. 2009;326:1694–7.
25. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, Comparative Sequencing Program NISC, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324(5931):1190–2.
26. Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL. The microbiome extends to subepidermal compartments of normal skin. Nat Commun. 2013;4:1431.
27. Sanchez Rodriguez R, Pauli ML, Neuhaus IM, Yu SS, Arron ST, Harris HW, Yang SH, Anthony BA, Sverdrup FM, Krow-Lucal E, MacKenzie TC, Johnson DS, Meyer EH, Löhr A, Hsu A, Koo J, Liao W, Gupta R, Debbaneh MG, Butler D, Huynh M, Levin EC, Leon A, Hoffman WY, McGrath MH, Alvarado MD, Ludwig CH, Truong HA, Maurano MM, Gratz IK, Abbas AK, Rosenblum MD.Memory regulatory T cells reside in human skin. J Clin Invest. 2014;124(3):1027–36.
28. Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Terán LM.Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol. 2010;135(1):1–11.
29. Hooper LV, Littman DR, Macpherson AJ.Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268–73.
30. Naik S, Bouladoux N, Wilhelm C, Molloy MJ, Salcedo R, Kastenmuller W, Deming C, Quinones M, Koo L, Conlan S, Spencer S, Hall JA, Dzutsev A, Kong H, Campbell DJ, Trinchieri G, Segre JA, Belkaid Y. Compartmentalized control of skin immunity by resident commensals. Science. 2012;337(6098):1115–9.
164
https://t.me/medicina_free
A. Faga et al.
31. Gallo RL, Nakatsuji T.Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol. 2011;131(10):1974–80.
32. Kostarnoy AV, Gancheva PG, Logunov DY, Verkhovskaya LV, Bobrov MA, Scheblyakov DV, Tukhvatulin AI, Filippova NE, Naroditsky BS, Gintsburg AL. Topical bacterial lipopolysaccharide application affects inammatory response and pro­motes wound healing. J Interferon Cytokine Res. 2013;33(9):514–22.
33. Kanno E, Kawakami K, Ritsu M, Ishii K, Tanno H, Toriyabe S, Imai Y, Maruyama R, Tachi M. Wound healing in skin promoted by inoculation with Pseudomonas aeruginosa PA01: the critical role of tumor necrosis factor-α secreted from inltrating neu­trophils. Wound Repair Regen. 2011;19(5):608–21.
34. Ferreira MO, Costa PC, Bahia MF. Effect of São Pedro do Sul thermal water on skin irritation. Int J Cosmet Sci. 2010;32(3):205–10.
35. Goldman MP, Merial-Kieny C, Nocera T, Mery S.Comparative benet of two thermal spring waters after photodynamic therapy procedure. J Cosmet Dermatol. 2007;6(1):31–5.
36. Barolet D, Lussier I, Mery S, Merial-Kieny C.Benecial effects of spraying low mineral content thermal spring water after fractional photothermolysis in patients with dermal melasma. J Cosmet Dermatol. 2009;8(2):114–8.
37. Faga A, Nicoletti G, Gregotti C, Finotti V, Nitto A, Gioglio L.Effects of thermal water on skin regenera­tion. Int J Mol Med. 2012;29(5):732–40.
38. Nicoletti G, Corbella M, Jaber O, Marone P, Scevola D, Faga A. Non-pathogenic microora of a spring water with regenerative properties. Biomed Rep. 2015;3(6):758–62.
39. Aries MF, Fabre P, Duplan H, Hernandez Pigeon H, Galliano MF, Castex Rizzi N, Bessou Touya S, Nguyen T. I-modulia, an Aquaphilus dolomiae extract, stimulates innate immune response through toll like receptor activation. J Am Acad Dermatol. 2014;70(Suppl 1):AB63.
40. Castex-Rizzi N, Charveron M, Merial-Kieny C. Inhibition of TNF-alpha induced-adhesion mol­ecules by Avène thermal spring water in human endothelial cells. J Eur Acad Dermatol Venereol. 2011;25(Suppl 1):6–11.
41. Mahé YF, Martin R, Aubert L, Billoni N, Collin C, Pruche F, Bastien P, Drost SS, Lane AT, Meybeck A.Induction of the skin endogenous protective mito­chondrial MnSOD by Vitreoscilla liformis extract. Int J Cosmet Sci. 2006;28(4):277–87.
42. Mahé YF, Perez MJ, Tacheau C, Fanchon C, Martin R, Rousset F, Seite S. A new Vitreoscilla liformis extract grown on spa water-enriched medium acti­vates endogenous cutaneous antioxidant and antimi­crobial defenses through a potential toll-like receptor 2/protein kinase C, zeta transduction pathway. Clin Cosmet Investig Dermatol. 2013;6:191–6.
43. Nicoletti G, Saler M, Pellegatta T, Malovini A, Faga A, Scalise A, Riva F. Effects of a spring water on human skin broblasts invitro cultures: preliminary results. Acta Vulnologica. 2016;14(4):196–201.
44. Nicoletti G, Saler M, Pellegatta T, Tresoldi MM, Bonfanti V, Malovini A, Faga A, Riva F. Ex-vivo regenerative effects of a spring water. Biomed Rep. 2017;7:508–14.
45. Jousson O. Culture-independent versus culture­dependent approaches for microbial community anal­ysis of a thermal spring with therapeutic properties. EMBL Symposium Heidelberg, Germany, 27–30 Jun 2017 New Approaches and Concepts in Microbiology, Poster n152.
symposia/2017/EES17-05/.
46. Pedron R, Esposito A, Bianconi I, Pasolli E, Tett A, Asnicar F, Cristofolini M, Segata N, Jousson O. Genomic and metagenomic insights into the microbial community of a thermal spring. Microbiome. 2019 23;7(1):8.
s40168-019-0625-6.
47. Lobanovska M, Pilla G. Penicillin’s discovery and antibiotic resistance: lessons for the future? Yale J Biol Med. 2017;90(1):135–45.
https://www.embo-embl-symposia.org/
https://doi.org/10.1186/
Erythropoietin: AnInnovative
https://t.me/medicina_free
Therapeutic Approach inThermal Trauma
ChristinaIreneGünter andHans-GüntherMachens
16
16.1 Introduction
Erythropoietin (EPO), whose existence had been postulated already more than a century ago [1], is an endogenous hormone that is produced by bro­blasts of the renal parenchyma depending on the partial pressure of oxygen in the peripheral blood. It controls the differentiation of erythrocytes in the bone marrow. The rst isolation of the protein succeeded half a century ago (1953) [2]. However, it took more than a quarter of a century (1984) to develop genetically modied hamster cells, which produced recombinant human EPO.Only thereaf­ter the pharmaceutical mass-production could start. In the meantime, EPO has become indis­pensable in clinical routine: in anemia of end­stage renal failure, in tumor-induced anemia, and before donating autologous blood [3]. About 15years ago, rst papers were published on the non-erythropoietic effects of EPO [4].
16.2 EPO Eects After Trauma
Since then, numerous publications have demon­strated that EPO plays a key role in the response to both acute and chronic tissue damage. EPO inhibits the initial inammatory response in a
C. I. Günter (*) · H.-G. Machens Department for Plastic Surgery and Hand Surgery, Klinikum rechts der Isar, Technical University of Munich, Germany
variety of tissues, thereby facilitating healing [ Also in the regenerative phases of wound heal­ing, various EPO effects have already been pub­lished. These include, for example, the inhibition of apoptosis [6, 7], which has been described in particular for endothelial cells of the capillaries and other small blood vessels that run in the immediate vicinity of the trauma zone. These are often damaged by the reactions of the inamma­tory phase and because of apoptosis. This in turn means that thromboses develop, and thus the trauma zone is ultimately enlarged.
The stem cell recruitment [8] is described, for example, for endothelial progenitor cells, which are recruited locally and from the bone marrow. Effects on mesenchymal stem cells have also been described. In vitro experiments conrmed the effect of EPO on human dermal mesenchy­mal stem cells cultured under hypoxia condi­tions. In addition, increased concentrations of IL-6 were added to the culture medium, which alone had a markedly antiproliferative effect. In addition, EPO added to the culture medium showed an increased proliferation rate [
The release of different growth factors [10] is also inuenced by EPO. Angiogenesis is stimu­lated on the one hand by the release of relevant growth factors and on the other hand by the above-described effects of stem cell recruitment and inhibition of apoptosis. The increase in re­epithelialization is also caused by the secreted growth factors [10]. Comprehensive reviews of the acute and longer-term anti- inammatory
5].
9].
© Springer Nature Switzerland AG 2019 D. Duscher, M. A. Shiffman (eds.), Regenerative Medicine and Plastic Surgery,
https://doi.org/10.1007/978-3-030-19958-6_16
165